InvestorsHub Logo
Followers 29
Posts 1812
Boards Moderated 0
Alias Born 03/14/2009

Re: jaiguruji7 post# 198575

Friday, 06/14/2024 9:40:43 AM

Friday, June 14, 2024 9:40:43 AM

Post# of 198997
If you run the numbers, shares, float, outstanding, cap, and the normal flow of business for any pharma that gets any 2 products successfully to market, even with average-good sales trends, and the reduce the cap to $1 billion or less, a stated goal, you'd eventually see this stock get into the $2-$4 dollar pps range. I can give you several biopharmas that started the same way and size, and are still going well today.
The one I did the best with personally, went from .08c pps, on up to $8.00 pps, volatility moves today ranging it from about $6.45 - $8.19 pps monthly. (I sold off too soon in the $4.00 range about 11 years ago.)
You're right though. Such a strategy in the trips and getting into $1.00 - $2.00 pps in a year or two is possible, and you'd be flush silly. The partner agreements they're continuing to set up now, will get you that surge to $1.00 + pps if they get it done.

GLTY